Evidence map›Paper›PMID 33418911›Full record

ArticleMarine drugs2021

A Multi-Omics Characterization of the Natural Product Potential of Tropical Filamentous Marine Cyanobacteria.

Tiago Leão, Mingxun Wang, Nathan Moss, Ricardo da Silva, Jon Sanders, Sergey Nurk, Alexey Gurevich, Gregory Humphrey, Raphael Reher, Qiyun Zhu and 11 more

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Fatuamide A, a Hybrid PKS/NRPS Metallophore from aJournal of natural products · 2025
    Article
  8. Review
  9. Article
  10. More than just an eagle killer: The freshwater cyanobacteriumProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 3 countries.

Tiago LeãoCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA 92037, USA.
Mingxun WangSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0001-7647-6097
Nathan MossCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA 92037, USA.
Ricardo da SilvaSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0001-6378-0479
Jon SandersDepartment of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0001-6077-4014
Sergey NurkCenter for Algorithmic Biotechnology, St. Petersburg State University, St. Petersburg 199004, Russia.
Alexey GurevichCenter for Algorithmic Biotechnology, St. Petersburg State University, St. Petersburg 199004, Russia.ORCID 0000-0002-5855-3519
Gregory HumphreyDepartment of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA.
Raphael ReherCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA 92037, USA.ORCID 0000-0002-5858-1173
Qiyun ZhuDepartment of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA.
Pedro Belda-FerreDepartment of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA.
Evgenia GlukhovCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA 92037, USA.
Syrena WhitnerCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA 92037, USA.
Kelsey L AlexanderCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA 92037, USA.ORCID 0000-0002-4727-5349
Robert RexCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA 92037, USA.
Pavel PevznerDepartment of Computer Science and Engineering, University of California San Diego, La Jolla, CA 92093, USA.
Pieter C DorresteinCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA 92037, USA.
Rob KnightDepartment of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA.
Nuno BandeiraSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, USA.
William H GerwickCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA 92037, USA.ORCID 0000-0003-1403-4458
Lena GerwickCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA 92037, USA.
Scripps Institution of Oceanography · USUniversity of California San Diego · USSt Petersburg University · RUCornell University · USUniversidade de São Paulo · BRUniversity of Hawaiʻi at Mānoa · US

Funding

Training Program in Marine BiotechnologyT32GM067550 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GERWICK, WILLIAM HENRY · 2004 to 2019
$2.0M
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 13425-13-7National Institute of Health GM118815NIH HHS GM107550NIH HHS T32 GM067550Russian Science Foundation 19-16-00049
6 · The paper itself

Abstract

Microbial natural products are important for the understanding of microbial interactions, chemical defense and communication, and have also served as an inspirational source for numerous pharmaceutical drugs. Tropical marine cyanobacteria have been highlighted as a great source of new natural products, however, few reports have appeared wherein a multi-omics approach has been used to study their natural products potential (i.e., reports are often focused on an individual natural product and its biosynthesis). This study focuses on describing the natural product genetic potential as well as the expressed natural product molecules in benthic tropical cyanobacteria. We collected from several sites around the world and sequenced the genomes of 24 tropical filamentous marine cyanobacteria. The informatics program antiSMASH was used to annotate the major classes of gene clusters. BiG-SCAPE phylum-wide analysis revealed the most promising strains for natural product discovery among these cyanobacteria. LCMS/MS-based metabolomics highlighted the most abundant molecules and molecular classes among 10 of these marine cyanobacterial samples. We observed that despite many genes encoding for peptidic natural products, peptides were not as abundant as lipids and lipopeptides in the chemical extracts. Our results highlight a number of highly interesting biosynthetic gene clusters for genome mining among these cyanobacterial samples.

Indexed as

Biological ProductsChromatography, High Pressure LiquidCyanobacteriaGenome, BacterialGenomicsMarine BiologyMass SpectrometryMetabolomicsMultigene FamilyPhylogenyTropical ClimateBiological Productsbiosynthetic potentialgenomicsmarine cyanobacteriametabolomicsnatural products

Identifiers

PMID33418911
PMCPMC7825088
OpenAlexW3118274032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.